Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment

Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment

Xiao Liang,* Yudi Wang,* Hui Shi, Mengmeng Dong, Haobo Han, Quanshun Li Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Changchun, 130012, People’s Republic of China*These authors contributed equally to this workC...

Full description

Bibliographic Details
Main Authors: Liang X, Wang Y, Shi H, Dong M, Han H, Li Q
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:International Journal of Nanomedicine
Subjects:
micelle
aptamer
nucleolin
multidrug resistance
tumor targeting
Online Access:https://www.dovepress.com/nucleolin-targeting-as1411-aptamer-modified-micelle-for-the-co-deliver-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/nucleolin-targeting-as1411-aptamer-modified-micelle-for-the-co-deliver-peer-reviewed-article-IJN

Similar Items